BRIDGEWATER, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical…
NEEDHAM, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage…
CHICAGO, March 20, 2025 (GLOBE NEWSWIRE) -- Pathos AI, (www.pathos.com), a clinical-stage biotechnology company focused on re-engineering drug development through…
MONTREAL and CHARLOTTE, N.C., March 20, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the…
Transaction is part of the Company’s new corporate strategy to become a revenue generating biotechWARRINGTON, Pa., March 20, 2025 (GLOBE…
REYOBIQ™ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and Recurrent Glioblastoma (GBM) HOUSTON, March…
Achieved First-Ever Annual Operating ProfitBottom Line Improved by RMB332.7 Million YoY in 2024Operating Expenses as a Percentage of Revenues Decreased…
Olio Labs Identifies Why Women Experience Stronger Side Effects from GLP-1 DrugsThe Company's AI-Powered Combination Design Engine (CoDE) Maps Biological…
Company Ranked in the Top 35% of All Rated Companies Underscoring the Company's Commitment to Good Sustainability Practices THE WOODLANDS,…
COLUMBUS, Ohio, March 19, 2025 /PRNewswire/ -- Computed Tomography (CT) scanning, once primarily associated with medical imaging, has now become an…